RECENTLY ADDED PODCASTS
Dr. Olga Klinkova reviews the definitions and common facts regarding urinary tract infections. She differentiates between complicated and uncomplicated UTIs, upper and lower tract urinary tract infections, as well as the clinical features of pyelonephritis. She also discusses the management of MDRO-related urinary tract infections. The lecture is presented in a case-based format to help the learner improve their management skills through the discussion of typical patient-based scenarios.
Dr. Toney presents an overview of adult vaccinations, focusing on the vaccines that are most important and relevant for the adult patient. He begins by discussing pneumococcal vaccines, whose guidelines can often be confusing because of the two different types of vaccines and their distinct administration schedules. He next talks about the influenza vaccine, differentiating the different types of vaccines, the efficacy of the flu shot, and potential future flu vaccine products. Next, he discusses the TDAP and the importance of receiving this vaccine given waning adult immunity for Pertussis. Dr. Toney also touches upon Shingles immunization and the significant advance of the recombinent shingles vaccine that is now available. Lastly, he discusses the MMR, Meningococcus, and Hepatitis vaccines.
Dr. Toney, Professor of Medicine in the Division of Infectious Diseases at the University of South Florida, conducts a case-based discussion regarding Infectious diseases syndromes for which it is essential that a provider not miss the diagnosis in an ambulatory care setting. Dr. Toney initiates each case by presenting a case, then providing choices of possible answers, followed by clinical pearls relevant to the case. At the conclusion of this informative and interactive presentation, it is hoped that the audience will have a greater understanding of several critical ID ambulatory care emergencies that every provider needs to recognize.
Dr. Aliyah Baluch, Chief BMT ID clinician at the Moffitt Cancer Center and Research Institute reviews 3 interesting BMT-related ID cases and offers insights into their management. From a lecture originally recorded in December, 2019.
By Tiffany Ward
Dr. Ward begins her presentation by reviewing the impact of beta-lactam allergies on the healthcare system. She then discusses the classification system for the different types of hypersensitivity reactions. The significance of beta-lactam allergy cross reactivity is then mentioned. She goes on to explain how beta-lactam allergy testing is performed. Lastly, she identifies strategies to improve the documentation of beta-lactam allergy reporting.
By Kami Kim, MD
Dr. Kami Kim, Chief of Infectious Diseases at the University of South Florida College of Medicine, discusses an important subset of emerging infections: sexually transmitted diseases (STIs). She initially reviews the current epidemiology of STIs in the U.S. She differentiates the more common and less common STIs. She goes on to discuss risk factors for sexually transmitted infections. She focuses on Neisseria gonorrhea infections, and discusses epidemiology, drug resistance, and treatment changes. She closes by sharing information on the diverse syndromes associated with Chlamydia trachomatis, including genital ulcer disease, urethritis, and cervicitis, extragenital infections, and pelvic inflammatory disease, and shares general treatment strategies and pitfalls.
Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, discusses the recent updates to the diagnosis and management of community acquired pneumonia. Dr. Klinkova begins her talk by referring to the recently introduced IDSA-ATS guidelines, released in August, 2019. She then discusses updates in the microbiology of CAP, including the most likely organisms, the role of MRSA, atypicals and the significance of viral pathogens. She then mentions diagnostic modalities and the relevance of clinical prediction algorithms such as CURB-65 and the Pneumonia Severity Index (PSI). Treament considerations including outpatient versus inpatient, and inpatient non-severe versus inpatient severe management are also differentiated. Specific treatment agents and therapy durations are also mentioned. Lastly, she discusses options for the management of MRSA pneumonia and aspiration syndromes.
Dr. Ju Hee Katzman begins her lecture by discussing some basic epidemiology of Tuberculosis, a major killer worldwide and still a significant infectious cause of mobility in the U.S. Dr. Katzman reviews the traditional diagnostic modalities for diagnosing TB (including expectorated sputum samples for smear and culture). She then goes on to discuss specific molecular techniques for diagnosing TB that will play an increasingly larger role in the future. Lastly, she touches upon the ways in which AI (Artificial Intelligence) can be utilized to detect and treat active tuberculosis in settings where health provider availability is greatly challenged.